Bitter Melon Extract (Momordica charantia) — Supplements
Insulin-mimicking proteins (polypeptide-p, charantin) with AMPK activation; 10 RCTs in type 2 diabetes showing 10-15% fasting glucose reduction; traditional Ayurvedic and TCM antidiabetic herb.
Overview
Bitter melon (Momordica charantia, karela, bitter gourd) is a tropical vine fruit used for millennia in Ayurvedic, traditional Chinese, and Caribbean medicine as an antidiabetic remedy. It contains several bioactive compounds with insulin-mimicking or insulin-sensitizing properties: polypeptide-p (a plant insulin analog), vicine, charantin (a mixture of steroidal saponins), and cucurbitane-type triterpenoids (momordicosides). A 2011 randomized controlled trial (Fuangchan et al., Journal of Ethnopharmacology, n=95 type 2 diabetics) compared bitter melon 2,000 mg/day to metformin 1,000 mg/day over 4 weeks and found significant fasting glucose reduction in both groups, with bitter melon inferior to metformin but superior to placebo. A 2020 Cochrane review and systematic review (Leung et al.) analyzed 10 RCTs (n=1,045) and found modest but consistent fasting glucose reduction of approximately 10-15% versus placebo in type 2 diabetic patients. Mechanistic evidence in animal and cell studies shows bitter melon activates AMPK (the cellular energy sensor that metformin activates), stimulates GLUT4 translocation, and inhibits alpha-glucosidase (slowing starch digestion). The evidence base is predominantly in type 2 diabetes; human data for pre-diabetes or general metabolic optimization is limited.
Indications
- Type 2 diabetes — adjunctive glycemic support
- Pre-diabetes — insulin sensitization
- Metabolic syndrome
- PCOS — insulin resistance component
Mechanism of Action
Polypeptide-p (p-insulin) is a 17-kDa plant-derived peptide structurally similar to bovine insulin that binds the insulin receptor and stimulates glucose uptake in adipose tissue and skeletal muscle — an 'insulin mimetic' mechanism unique to Momordica charantia
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Bitter melon standardized extract (Momordica charantia) | 1,000–2,000 mg | Once to twice daily with meals | The key Fuangchan RCT used 2,000 mg/day; standardize to charantin content or total bitter melon extract from fruit |
Safety & Contraindications
- Generally well tolerated — most common side effects are GI (abdominal discomfort, diarrhea, flatulence); mild and dose-dependent
- Hypoglycemia risk when combined with insulin or sulfonylureas — monitor glucose
- Avoid in pregnancy — bitter melon has abortifacient and uterine-stimulant properties (polypeptide-p and vicine have been shown to stimulate uterine contractions in animal studies)
- G6PD deficiency: vicine content may trigger hemolysis in G6PD-deficient individuals (similar mechanism to fava bean-induced favism) — screen in at-risk populations (Mediterranean, Middle Eastern, African descent)
- Avoid in children — insulin-mimicking effects can cause dangerous hypoglycemia
- Bitter melon juice is more potent than supplement forms — standardized extract preferred for predictable dosing